one8zero8 LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,350 shares of the company's stock, valued at approximately $278,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Frazier Financial Advisors LLC increased its position in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after purchasing an additional 104 shares during the last quarter. Promus Capital LLC bought a new stake in shares of Cardinal Health in the 4th quarter worth about $30,000. AM Squared Ltd bought a new stake in shares of Cardinal Health in the 3rd quarter worth about $33,000. Kentucky Trust Co bought a new stake in shares of Cardinal Health during the 4th quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC grew its position in shares of Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after buying an additional 144 shares during the last quarter. Institutional investors own 87.17% of the company's stock.
Wall Street Analysts Forecast Growth
CAH has been the subject of a number of recent research reports. Citigroup boosted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. JPMorgan Chase & Co. boosted their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Morgan Stanley boosted their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Finally, Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $139.36.
Read Our Latest Stock Report on CAH
Cardinal Health Stock Performance
Shares of NYSE:CAH traded up $0.90 during trading on Thursday, reaching $133.02. The company had a trading volume of 1,737,938 shares, compared to its average volume of 1,962,640. The firm's fifty day moving average is $126.94 and its 200 day moving average is $119.78. The firm has a market capitalization of $32.13 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $133.08.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio is presently 37.69%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
